Poly Medicure per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹31.09₹31.79₹34.13₹26.92₹18.69
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹31.06₹31.75₹34.11₹26.90₹18.67
₹306.45₹306.45₹272.95₹153.18₹129.41
₹197.06₹185.01₹164.80₹143.35₹116.24
—₹23.75₹23.79₹27.73₹19.89
−₹6.68−₹6.68−₹8.28−₹1.14−₹5.05
—₹3.50₹2.99₹2.99₹2.50
10.110.110.19.69.6
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

POLYMED₹1,461.90

Poly Medicure Ltd.

· Pharma & Health
₹ CrorePeersPFIZERRAINBOWONESOURCEKIMSJUBLPHARMAVIJAYAINDGNGRANULESMcap ₹14,818 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS18.6926.9234.1331.7931.09
Diluted EPS18.6726.9034.1131.7531.06
Book Value per Share129.41153.18272.95306.45306.45
Revenue per Share116.24143.35164.80185.01197.06
Cash Flow per Share19.8927.7323.7923.75—
Free Cash Flow per Share-5.05-1.14-8.28-6.68-6.68
Dividends per Share2.502.992.993.50—
Shares Outstanding (cr)9.69.610.110.110.1
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.